60(top 2%)
papers
1.3K(top 2%)
citations
19(top 2%)
h-index
35(top 2%)
g-index
65
all documents
1.5K
doc citations
579
citing journals

Top Articles

#TitleJournalYearCitations
1Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patientsPLoS ONE2017174
2JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositisBrain2018169
3Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patientsAutoimmunity Reviews201897
4Integrated classification of inflammatory myopathiesNeuropathology and Applied Neurobiology201792
5Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositisAnnals of the Rheumatic Diseases201771
6Chronic hepatitis C virus infection, a new cardiovascular risk factor?Liver International201659
7Efficacy and safety of rituximab for systemic lupus erythematosus‐associated immune cytopenias: A multicenter retrospective cohort study of 71 adultsAmerican Journal of Hematology201856
8Development of a multivariate prediction model of intensive care unit transfer or death: A French prospective cohort study of hospitalized COVID-19 patientsPLoS ONE202054
9SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic ThrombocytopeniaThrombosis and Haemostasis202150
10Neutrophil–Platelet and Monocyte–Platelet Aggregates in COVID-19 PatientsThrombosis and Haemostasis202041
11Different patterns and specific outcomes of large-vessel involvements in giant cell arteritisJournal of Autoimmunity201936
12Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic AbnormalitiesPLoS ONE201533
13Anti–Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular EdemaOphthalmology202232
14Biotherapies in UveitisJournal of Clinical Medicine202030
15Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept202229
16Osseous sarcoidosis: A multicenter retrospective case-control study of 48 patientsJoint Bone Spine201927
17Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine wardAutoimmunity Reviews202126
18Direct medical costs associated with the extrahepatic manifestations of hepatitis C infection in EuropeJournal of Viral Hepatitis201824
19Risk factors for hydroxychloroquine retinopathy in systemic lupus erythematosus: a case–control study with hydroxychloroquine blood-level analysisRheumatology202024
20French Patients with Hepatitis C Treated with Direct-Acting Antiviral Combinations: The Effect on Patient-Reported OutcomesValue in Health201821
21CD8+T-bet+ cells as a predominant biomarker for inclusion body myositisAutoimmunity Reviews201921
22Sarcoidosis with Takayasu arteritis: a model of overlapping granulomatosis. A report of seven cases and literature reviewInternational Journal of Rheumatic Diseases201820
23Global versus individual muscle segmentation to assess quantitative MRI-based fat fraction changes in neuromuscular diseasesEuropean Radiology202119
24Efficacy and patient satisfaction in the use of subcutaneous immunoglobulin immunotherapy for the treatment of auto-immune neuromuscular diseasesAutoimmunity Reviews201818
25Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effectiveKidney International201818
26Iron deficiency screening is a key issue in chronic inflammatory diseases: A call to actionJournal of Internal Medicine202217
27Management of immune-related adverse events associated with immune checkpoint inhibitors in cancer patients: a patient-centred approachInternal and Emergency Medicine202016
28Anti-RNP antibodies delineate a subgroup of myositis: A systematic retrospective study on 46 patientsAutoimmunity Reviews202014
29Edematous myositis: a clinical presentation first suggesting dermatomyositis diagnosisBrain Pathology202013
30Cerebrovascular Ischemic Events in Patients With Takayasu ArteritisStroke202212
31Immunomodulatory role of Interleukin-33 in large vessel vasculitisScientific Reports202011
32HCV-related lymphoproliferative disorders in the direct-acting antiviral era: From mixed cryoglobulinaemia to B-cell lymphomaJournal of Hepatology202211
33Towards a Common Definition for the Diagnosis of Iron Deficiency in Chronic Inflammatory DiseasesNutrients202211
34Perceived HIV‐related physical fatigue, sociodemographic characteristics and physical activity: A cross‐sectional studyJournal of Clinical Nursing201910
35Impact of aging on phenotype and prognosis in IgA vasculitisRheumatology20219
36Emerging Molecular Targets for the Treatment of Refractory SarcoidosisFrontiers in Medicine20208
37Expanding the spectrum of HIV-associated myopathyJournal of Neurology, Neurosurgery and Psychiatry20197
38A descriptive study of IgG4-related disease in children and young adultsAutoimmunity Reviews20227
39Iron Deficiency in Patients with Inflammatory Bowel Diseases: A Prospective Multicenter Cross-Sectional StudyDigestive Diseases and Sciences20227
40Endoplasmic reticulum‐stress and unfolded protein response‐activation in immune‐mediated necrotizing myopathyBrain Pathology20227
41Old and New Challenges in Uveitis Associated with Behçet’s DiseaseJournal of Clinical Medicine20216
42Diagnosis and Management of Heart Failure in Elderly Patients from Hospital Admission to Discharge: Position PaperJournal of Clinical Medicine20216
43Peripheral neuropathy and livedoid vasculopathyJournal of Neurology20226
44Cytokine profile as a prognostic tool in coronavirus disease 2019. Comment on “Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome” by Quartuccio et al. Joint Bone Spine. 2020;87:191–93Joint Bone Spine20215
45Reply: A child with severe juvenile dermatomyositis treated with ruxolitinibBrain20184
46Germinal Center T follicular helper (GC-Tfh) cell impairment in chronic HIV infection involves c-Maf signalingPLoS Pathogens20214
47Brain Biopsy for Neurological Diseases of Unknown Etiology in Critically Ill Patients: Feasibility, Safety, and Diagnostic YieldCritical Care Medicine20224
48Treat to target in Behcet's disease: Should we follow the paradigm of other systemic rheumatic diseases?Clinical Immunology20234
49Differential diagnosis between sarcoidosis and granulomatosis with polyangiitis in a patient with leptomeningeal, cavernous sinus and pituitary lesionsQJM - Monthly Journal of the Association of Physicians20173
50Different Control Populations May Lead to Different Understanding of Hydroxychloroquine Blood Levels as a Risk Factor for Retinopathy: Comment on the Article by Petri et alArthritis and Rheumatology20212